3SBio Inc. (HKG:1530)
19.64
-0.06 (-0.30%)
Jun 4, 2025, 4:08 PM HKT
3SBio Employees
3SBio had 5,577 employees as of December 31, 2024. The number of employees increased by 166 or 3.07% compared to the previous year.
Employees
5,577
Change (1Y)
166
Growth (1Y)
3.07%
Revenue / Employee
1.74M HKD
Profits / Employee
398.86K HKD
Market Cap
46.46B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
Innovent Biologics | 5,659 |
WuXi Biologics | 12,575 |
CSPC Pharmaceutical Group | 21,400 |
Sino Biopharmaceutical | 24,379 |
Akeso | 3,035 |
3SBio News
- 6 days ago - Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma - Benzinga
- 15 days ago - Pfizer Thinks Bigger With 3SBio Deal - Seeking Alpha
- 15 days ago - Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia
- 15 days ago - Pfizer strikes deal with China's 3SBio to license cancer drug - CNBC
- 15 days ago - Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal - Benzinga